combining glp-1 receptor agonist with dpp-4 inhibitor not recommended guideline do combine inhibitors agonists guidance What classes of diabetes What drug combination with DPP-4
Description
Bossowski A, Moniuszko M, Dbrowska M, et al
L., et al., Vildagliptin, a Dipeptidyl PeptidaseIV Inhibitor, Improves ModelAssessed Cell Function in Patients With Type 2 Diabetes, Journal of Clinical Endocrinology and Metabolism 90, no

Thus, hepatic DPP4 expression in NAFLD may be directly associated with increased DPP4 serum level and may be involved in hepatic lipogenesis and liver injury

Monitoring Protocol Check a trough digoxin level 5 to 7 days after GLP-1 RA initiation and again after each dose escalation
